PLASMA-LIPIDS IN HIV-INFECTED PATIENTS - A PROSPECTIVE-STUDY IN 95 PATIENTS

被引:129
作者
CONSTANS, J
PELLEGRIN, JL
PEUCHANT, E
DUMON, MF
PELLEGRIN, I
SERGEANT, C
SIMONOFF, M
BROSSARD, G
BARBEAU, P
FLEURY, H
CLERC, M
LENG, B
CONRI, C
机构
[1] HOP HAUT LEVEQUE,SERV MED INTERNE & PATHOL INFECT,PESSAC,FRANCE
[2] HOP PELLEGRIN,VIROL LAB,F-33076 BORDEAUX,FRANCE
[3] HOP ST ANDRE,BIOCHIM LAB,BORDEAUX,FRANCE
[4] CTR ETUD NUCL BORDEAUX GRADIGNAN,GRADIGNAN,FRANCE
关键词
CHOLESTEROL; HIV; INTERFERON-ALPHA; LIPIDS; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;
D O I
10.1111/j.1365-2362.1994.tb02185.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study aimed to determine plasma lipid levels in 95 HIV-infected patients divided into four groups according to the CD4 lymphocyte counts comparatively to a control group of 20 HIV-negative normolipidaemic subjects. A relationship between lipidic abnormalities and immune or nutritional status was also investigated. The patients below 200 CD4 lymphocyte mm(-3) (groups 1 and 2) had significantly lower total cholesterol than the controls. The patients below 400 CD4 lymphocytes mm(-3) (groups 1, 2, 3) had significantly higher triglycerides and Lp(a) but lower LDL-cholesterol than the controls. In all HIV-positive patients, whatever their CD4 lymphocyte count, HDL-C and apoA1 were lower than in the controls. By multivariate analysis triglycerides were positively correlated to acute opportunistic infections and to interferon-alpha levels, while cholesterol was negatively correlated to TNF-alpha, and LDL-C was positively correlated to albuminaemia. The latter parameter was the only lipidic value to correlate with nutritional markers. The contamination route, or the presence of wasting, was not correlated to any lipidic disorder.
引用
收藏
页码:416 / 420
页数:5
相关论文
共 50 条
  • [31] Fatality Rate in HIV-infected Patients
    Akdemir Kalkan, Irem
    Demir, Yakup
    Celen, Mustafa Kemal
    FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2019, 24 (04): : 384 - 386
  • [32] Kidney diseases in HIV-infected patients
    Tourret, Jerome
    Tostivint, Isabelle
    Deray, Gilbert
    Isnard-Bagnis, Corinne
    NEPHROLOGIE & THERAPEUTIQUE, 2009, 5 (06): : 576 - 591
  • [33] Liver steatosis in HIV-infected patients
    Piroth, L
    AIDS REVIEWS, 2005, 7 (04) : 197 - 209
  • [34] Oral Candidosis in HIV-Infected Patients
    Egusa, Hiroshi
    Soysa, Niroshani S.
    Ellepola, Arjuna N.
    Yatani, Hirofumi
    Samaranayake, Lakshman P.
    CURRENT HIV RESEARCH, 2008, 6 (06) : 485 - 499
  • [35] HCV therapy in HIV-infected patients
    Sulkowski, Mark S.
    LIVER INTERNATIONAL, 2013, 33 : 63 - 67
  • [36] Lung Cancer in HIV-Infected Patients
    Mena, Alvaro
    Meijide, Hector
    Marcos, Pedro J.
    AIDS REVIEWS, 2016, 18 (03) : 138 - 144
  • [37] Tuberculous peritonitis in HIV-infected patients
    Cecchini, D.
    Paz, S.
    Poggi, S.
    Robles, M.
    Ambroggi, M.
    REVISTA ARGENTINA DE MICROBIOLOGIA, 2010, 42 (03): : 172 - 175
  • [38] Plasma cell disorders in HIV-infected patients: Epidemiology and molecular mechanisms
    Coker W.J.
    Jeter A.
    Schade H.
    Kang Y.
    Biomarker Research, 1 (1)
  • [39] Cardiovascular involvements in HIV-infected patients
    Alharethi, Rami
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2013, 11 (09) : 1227 - 1235
  • [40] Malignancies in HIV-Infected and AIDS Patients
    Ji, Yongjia
    Lu, Hongzhou
    INFECTIOUS AGENTS ASSOCIATED CANCERS: EPIDEMIOLOGY AND MOLECULAR BIOLOGY, 2017, 1018 : 167 - 179